Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 10/20 | 0.34 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28471119 | 1.00 | VCAM1 (0.40) | VCAM1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL309612 | 0.79 | VCAM1 (0.55) | VCAM1MEN1KMT2AKAT2B | |
| SCHEMBL29788706 | 0.78 | LMNA (0.39) | LMNASMN1; SMN2MEN1KMT2AHCAR3 | |
| SCHEMBL20600834 | 0.78 | LMNA (0.39) | LMNASMN1; SMN2MEN1KMT2AHCAR3 | |
| SCHEMBL19553760 | 0.74 | MAPT (0.55) | VCAM1LMNASMN1; SMN2KMT2AHCAR3 | |
| SCHEMBL1675905 | 0.73 | VCAM1 (0.44) | VCAM1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL14247533 | 0.72 | VCAM1 (0.47) | VCAM1SMN1; SMN2MEN1KMT2AMAPT | |
| SCHEMBL29258675 | 0.72 | VCAM1 (0.47) | VCAM1LMNAMEN1KMT2ACYP1A2 | |
| SCHEMBL14247077 | 0.72 | VCAM1 (0.51) | VCAM1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL4085561 | 0.71 | LMNA (0.41) | LMNASMN1; SMN2MEN1KMT2AHCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462516-A | Compound of formula I, preparation method and application thereof, and preparation method of Abeli intermediate compound A | 广东莱佛士制药技术有限公司 | 2025-02-18 | — | — | CN | disclosed |